Large study provides further reassurance about topical corticosteroid use in pregnancy.

Researchers from the Department of Clinical Pharmacology at Copenhagen University Hospital have published a large population-based propensity score matched comparative cohort study which found no association between topical corticosteroid use in pregnancy and an increased risk of SGA or low birth weight. Their results also suggested that moderate to large increased risks were unlikely, even with use of large amounts of […]

» Read more

Paternal exposure to antidiabetic medications associated with increased birth defect risks

A study published in the Annals of Internal Medicine has suggested that there may be an association between paternal preconception exposure to antidiabetic medication and increased birth defect risks. Of note, the findings suggested clinically relevant increased risks among those exposed to metformin. However, the potential for confounding by indication may also have been highlighted. More information available here. Photo […]

» Read more

No increased risk of malformation, miscarriage, stillbirth or neonatal death following mirtazapine use in pregnancy

Researchers based in Denmark have conducted a national population-based comparative cohort study which included between 895 and 1,900 mirtazapine exposed pregnancies (outcome dependent). The results indicated that mirtazapine exposure in pregnancy is not associated with increased risks of major congenital malformation, miscarriage, stillbirth or neonatal death. More details can be found here. Photo by Ben Blennerhassett on Unsplash

» Read more

Two studies investigating MS treatments in pregnancy

Researchers from Teva Pharmaceuticals have published a large case series of 647 glatiramer acetate exposed pregnancies that were reported to the global pharmacovigilance database. More information can be found here. Clinical researchers affiliated to two neurology departments in Western Australia have published a small case series of 14 pregnancies in 12 MS patients who had been exposed to ocrelizumab within […]

» Read more

Medication in pregnancy utilisation study using Swiss healthcare claims data

A collaboration of researchers from Lausanne University Hospital, and the Universities of Lausanne, Basel and Bern have published data from the Swiss Helsana claims dataset (2014-2018). The researchers described the medications most commonly utilised in the treatment of chronic medical conditions in Switzerland. More information can be found here. Photo by Campaign Creators on Unsplash

» Read more

Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic

ENTIS research led by Dr Michael Ceulemans (Lareb TIS, Netherlands) and Prof Hedvig Nordeng (Pharmacoepidemiology and Drug Safety Research Group, University of Oslo) has been published describing the prevalence of medication use in pregnancy and breastfeeding during the first wave of the COVID-19 pandemic. The research highlighted that perinatal medication use was highly prevalent during the first wave, underlining the […]

» Read more
1 8 9 10 11 12 23